Cargando…
Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images
BACKGROUND: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a newly defined autoimmune inflammatory demyelinating central nervous system (CNS) disease characterized by antibodies against MOG. Leptomeningeal enhancement (LME) on contrast-enhanced fluid-attenuated inversion recovery (C...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318903/ https://www.ncbi.nlm.nih.gov/pubmed/37409120 http://dx.doi.org/10.3389/fimmu.2023.1152235 |
_version_ | 1785068137549398016 |
---|---|
author | Li, Li Liu, Wen Cai, Qifang Liu, Yuqing Hu, Wenjing Zuo, Zhichao Ma, Qiuhong He, Siping Jin, Ke |
author_facet | Li, Li Liu, Wen Cai, Qifang Liu, Yuqing Hu, Wenjing Zuo, Zhichao Ma, Qiuhong He, Siping Jin, Ke |
author_sort | Li, Li |
collection | PubMed |
description | BACKGROUND: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a newly defined autoimmune inflammatory demyelinating central nervous system (CNS) disease characterized by antibodies against MOG. Leptomeningeal enhancement (LME) on contrast-enhanced fluid-attenuated inversion recovery (CE-FLAIR) images has been reported in patients with other diseases and interpreted as a biomarker of inflammation. This study retrospectively analyzed the prevalence and distribution of LME on CE-FLAIR images in children with MOG antibody-associated encephalitis (MOG-E). The corresponding magnetic resonance imaging (MRI) features and clinical manifestations are also presented. METHODS: The brain MRI images (native and CE-FLAIR) and clinical manifestations of 78 children with MOG-E between January 2018 and December 2021 were analyzed. Secondary analyses evaluated the relationship between LME, clinical manifestations, and other MRI measures. RESULTS: Forty-four children were included, and the median age at the first onset was 70.5 months. The prodromal symptoms were fever, headache, emesis, and blurred vision, which could be progressively accompanied by convulsions, decreased level of consciousness, and dyskinesia. MOG-E showed multiple and asymmetric lesions in the brain by MRI, with varying sizes and blurred edges. These lesions were hyperintense on the T2-weighted and FLAIR images and slightly hypointense or hypointense on the T1-weighted images. The most common sites involved were juxtacortical white matter (81.8%) and cortical gray matter (59.1%). Periventricular/juxtaventricular white matter lesions (18.2%) were relatively rare. On CE-FLAIR images, 24 (54.5%) children showed LME located on the cerebral surface. LME was an early feature of MOG-E (P = 0.002), and cases without LME were more likely to involve the brainstem (P = 0.041). CONCLUSION: LME on CE-FLAIR images may be a novel early marker among patients with MOG-E. The inclusion of CE-FLAIR images in MRI protocols for children with suspected MOG-E at an early stage may be useful for the diagnosis of this disease. |
format | Online Article Text |
id | pubmed-10318903 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103189032023-07-05 Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images Li, Li Liu, Wen Cai, Qifang Liu, Yuqing Hu, Wenjing Zuo, Zhichao Ma, Qiuhong He, Siping Jin, Ke Front Immunol Immunology BACKGROUND: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a newly defined autoimmune inflammatory demyelinating central nervous system (CNS) disease characterized by antibodies against MOG. Leptomeningeal enhancement (LME) on contrast-enhanced fluid-attenuated inversion recovery (CE-FLAIR) images has been reported in patients with other diseases and interpreted as a biomarker of inflammation. This study retrospectively analyzed the prevalence and distribution of LME on CE-FLAIR images in children with MOG antibody-associated encephalitis (MOG-E). The corresponding magnetic resonance imaging (MRI) features and clinical manifestations are also presented. METHODS: The brain MRI images (native and CE-FLAIR) and clinical manifestations of 78 children with MOG-E between January 2018 and December 2021 were analyzed. Secondary analyses evaluated the relationship between LME, clinical manifestations, and other MRI measures. RESULTS: Forty-four children were included, and the median age at the first onset was 70.5 months. The prodromal symptoms were fever, headache, emesis, and blurred vision, which could be progressively accompanied by convulsions, decreased level of consciousness, and dyskinesia. MOG-E showed multiple and asymmetric lesions in the brain by MRI, with varying sizes and blurred edges. These lesions were hyperintense on the T2-weighted and FLAIR images and slightly hypointense or hypointense on the T1-weighted images. The most common sites involved were juxtacortical white matter (81.8%) and cortical gray matter (59.1%). Periventricular/juxtaventricular white matter lesions (18.2%) were relatively rare. On CE-FLAIR images, 24 (54.5%) children showed LME located on the cerebral surface. LME was an early feature of MOG-E (P = 0.002), and cases without LME were more likely to involve the brainstem (P = 0.041). CONCLUSION: LME on CE-FLAIR images may be a novel early marker among patients with MOG-E. The inclusion of CE-FLAIR images in MRI protocols for children with suspected MOG-E at an early stage may be useful for the diagnosis of this disease. Frontiers Media S.A. 2023-06-20 /pmc/articles/PMC10318903/ /pubmed/37409120 http://dx.doi.org/10.3389/fimmu.2023.1152235 Text en Copyright © 2023 Li, Liu, Cai, Liu, Hu, Zuo, Ma, He and Jin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Li, Li Liu, Wen Cai, Qifang Liu, Yuqing Hu, Wenjing Zuo, Zhichao Ma, Qiuhong He, Siping Jin, Ke Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images |
title | Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images |
title_full | Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images |
title_fullStr | Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images |
title_full_unstemmed | Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images |
title_short | Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images |
title_sort | leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318903/ https://www.ncbi.nlm.nih.gov/pubmed/37409120 http://dx.doi.org/10.3389/fimmu.2023.1152235 |
work_keys_str_mv | AT lili leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages AT liuwen leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages AT caiqifang leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages AT liuyuqing leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages AT huwenjing leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages AT zuozhichao leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages AT maqiuhong leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages AT hesiping leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages AT jinke leptomeningealenhancementofmyelinoligodendrocyteglycoproteinantibodyassociatedencephalitisuncoveringnovelmarkersoncontrastenhancedfluidattenuatedinversionrecoveryimages |